Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592539 · ClinicalTrials.gov registry record
Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 78
- Enrollment target
NCT01592539: Completed study, sponsored by Creighton University.
NCT01592539 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01592539 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
The effects of high serum glucose on bone could be direct or could be indirect through its effects on the microvasculature. Previous studies by Rendell et al and Brugler et al have found significant differences in skin blood flow between diabetics and control. The investigators are proposing that blood flow measurements of the skin may be correlated with bone remodeling rates in iliac bone biopsies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-08 |
What the finished NCT01592539 record still lists
NCT01592539 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01592539 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01592539 about?
NCT01592539 is a clinical study titled "Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls". The effects of high serum glucose on bone could be direct or could be indirect through its effects on the microvasculature. Previous studies by Rendell et al and Brugler et al have found significant differences in skin blood flow between diabetics and control. The investigators are proposing that bl...
What is the current status of trial NCT01592539?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2012-05. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT01592539?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia